» Download Public Reports
About 400 reports
- Company report
- January 2013
- 32 pages
... For ethical drugs can be as high as 40%.3 In response, drug producers hedge their bets by submitting between three and four invented names per drug to medical regulators.4 Creating a suite of suitable names ...
January 2013
... For ethical drugs can be as high as 40%.3 In response, drug producers hedge their bets by submitting between three and four invented names per drug to medical regulators.4 Creating a suite of suitable names ...
April 2013
... Hexyontm/hexacima complements sanofi pasteur S product family of acp-ipv (acellular pertussis vaccine, inactivated poliovirus vaccine) combination vaccines. The new 6-in-1 vaccine will be available ...
February 2013
... Pp pharma planing feedback, registration & more general affymax shares fall as customer pauses pilot drug program by joseph walker affymax inc. (Affy) shares fell sharply thursday after ...
March 2013
... drugs, and sold companies at favorable prices for shareholders. Moreover, we believe they have significant credibility with the investment community. Each of our nominees qualifies as an independent ...
February 2013
... Opportunities than we have had in the past. In japan, specifically, during the year we built the joint venture with daiichi sankyo to ensure that in the vaccines space we can complement our new high end ...
March 2013
... hydroquinone Highly toxic to skin and linked to cancer Unstable Banned in several countries Major adverse events monobenzyl ether of hydroquinone or monobenzone (mbeh) Nearly irreversible ...
January 2013
... The broader context of an understanding of the drugs phenomenon. This new analysis allows us to draw some very important conclusions which have clear implications for eu policies and actions. As the report ...
January 2013
... For organised crime groups across europe today. Understanding the reality of the european drug market requires a holistic approach, following the economic chain from production, via trafficking, to consumption ...
January 2013
... Acids by inhibiting dna-dependent rna polymerase rifamycin sv sodium salt has a broad spectrum of activity targeted to the main enteropathogen microorganisms: Salmonella Shighella E ...
» Purchase Premium Reports
(From $ 250 - $ 10 988)
About 200 reports
- $ 11 691
- Industry report
- May 2013
- by Global Research & Data Services
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different European countries. The studies provide essential market information ...
May 2013
$ 7 701
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Eastern European countries. The studies provide essential market ...
May 2013
$ 5 174
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...
April 2013
$ 3 500
Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth Summary The leading business intelligence provide ...
May 2013
$ 2 514
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 5 European countries. The studies provide essential market information ...
March 2013
$ 2 000
TechNavio's analysts forecast the Car and Van Aftermarket Tires in Europe to grow at a CAGR of 1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing ...
April 2013
$ 2 000
This report provides data on the therapeutic development for Partial Seizure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
